Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × Anastrozole × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 4 Endometrial Neoplasms 4 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Low Grade Serous Ovarian Cancer 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Granulosa Cell Ovarian Cancer 1 Fallopian Tube Neoplasms 1 Carcinoma 1 Breast Diseases 1

Interventions

Paclitaxel 6 pembrolizumab 5 Carboplatin 4 liposomal doxorubicin 3 Gemcitabine 3 Cisplatin 3 Bevacizumab 3 trebananib 2 interferon gamma-1b 2 dostarlimab 2 catumaxomab 2 anlotinib 2 Topotecan 2 Radiotherapy, Intensity-Modulated 2 Ocoxin 2 Itraconazole 2 Hyperthermic Intraperitoneal Chemotherapy 2 Drug Therapy 2 Docetaxel 2 vistusertib 1 pertuzumab 1 peginterferon alfa-2b 1 olaparib 1 niraparib 1 nintedanib 1 lanreotide 1 enzastaurin 1 efineptakin alfa 1 durvalumab 1 atezolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02730923 2024-02-13

VICTORIA

Centre Leon Berard

Phase 1/2 Unknown

Carcinoma, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡